Lindsay Mark F.
SEC insider (Form 3/4/5 filer). CIK 0001835542. Director at Vivos Therapeutics, Inc. (VVOS). 1 reported Form 4/5 transaction since Sep 2024; latest on Sep 14, 2026. Located in LITTLETON, CO.
Companies Lindsay Mark F. has filed insider reports for
- Vivos Therapeutics, Inc. (VVOS): Director
Lindsay Mark F.
CIK: 0001835542
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
VVOS
Vivos Therapeutics, Inc.
Director